Dr Vikram Sharma
Profiles

Dr Vikram Sharma

Research Fellow

School of Biomedical Sciences (Faculty of Medicine and Dentistry)

Role

Head of Proteomics Core Facility

Qualifications

BSc (Hons) Biochemistry, 2001

MSc (Hons) Biochemistry (Research Masters), 2003
PhD (CSIR Fellow), Pharmacology and Toxicology, 2008 
PgCert in Academic Practice, 2016

Professional membership

BMSS

BBTS Red Cell SIG
Fellow of the HigherEducation Academy, UK

Roles on external bodies

I regularly review research articlesfrom PLOS ONE, Proteomics-Clinical Applications (Wiley), Canadian Journal ofPhysiology and Pharmacology, Drug Design, Development and Therapy, CurrentBiomarkers Findings,Diabetes, Metabolic Syndrome and Obesity: Targets andTherapy, Journal of Blood Medicine (Dovepress). Besides this, I regularly review/assess fellowship applications for The Royal College of Surgeons of England.

I am also an Editorial Board Member in Journal of Natural ScienceBiology and Medicine, BEMS Reports and EC Pharmacology & Toxicology Journal.

 

Teaching interests

Seminars on Proteomics and Data Analysis. Teaching and Training sessions in Mass Spectrometry based Proteomics for Undergraduates and Post Graduates. I am responsible for organising weekly research seminar series for SoBHS/ITSMED.

Lecturing in the following Modules:
BIOM3008
BIOM3026
BIOM5006
BIOM5001
BIOM5010
BHCS1004PP
BIO013
BHCS2007
BHCS2019
BHCS2002
BHCS3001
Personal Tutor: BHCS1001, BHCS1002
BHCS2027

Module Lead for BHCS2020 (Human Metabolism)

Research interests

I am running the Proteomics Core Services Laboratory located within the Systems Biology Facility. We offer various services involving LC-MS Based Proteomics and Bioinformatic Analysis of Proteomic Datasets. Besides this, I also provide specialist advice on experimental designs for a wide range of research projects.


My research primarily focusses on development of customised LC-MS based Proteomic Workflows for a wide range of applications. I have keen interest in epigenetic post translational modifications and their role in disease pathology, Cancer and toxic responses.

Phd Students:

1. Ms Charlotte Crowther: Analytical, toxicogenomics and modelling approaches to determine the impacts of radionuclides and metals.  ( Co-Supervisor)
2. Mr. Nizar Saeedi: Investigating Virulence of ST127 Uropathogenic Escherichia coli. ( Co-Supervisor)
3. Mr. Raed Garout: New methods for detection of Down's syndrome pregnancies. ( Co-Supervisor)
4. Ms Yeasmin Akhter: Proteomics based profiling of meningiomas. ( Co-Supervisor)

 

Current Masters Students:

Mr. Daniel Machin: Deciphering the mode of action of new generation Epigenetic modifiers in Cancer. 

Current Undergraduate Students on projects investigating novel drug targets in Acute Lymphoblastic Leukemia ( B-ALL):

Mr. Adam North
Ms Jasmin Mirzayan
Ms Abena Yeboah



Previous Undergraduate, Placement and Masters Students:

Mr. Jake Serle: Role of Epigenetic inhibitors in non small cell lung carcinoma. 

Ms Lucinda Burt: Deciphering the mode of action of new generation Epigenetic modifiers in Non Small Cell Lung Carcinoma 

Ms Maisie Fox: Epigenetic mechanisms underlying Acute Lymphoid Leukemia. 

Mr. Jordan Martin: Role of Hybrid Histone Deacetylase Inhibitors in Acute Lymphoid Leukemia

Potential New Positions:

Self Funded PhD/ResM applicants are encouraged to apply.

Grants & contracts

Projects Running in the facility:
RCUK-CONICYT ( Co-Investigator)
EU-FP7 Nanosolutions 
EU-FP7-SysVasc
EU-H2020 Transat ( Co-Investigator) 

Key publications are highlighted

Journals
Articles
Sareen N, Sequiera GL, Chaudhary R, Abu-El-Rub E, Chowdhury SR, Sharma V, Surendran A, Moudgil M, Fernyhough P & Ravandi A 2018 'Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior' Stem Cells Research and Therapy , DOI PEARL
Eymael J, Sharma S, Loeven MA, Wetzels JF, Mooren F, Florquin S, Deegens JK, Willemsen BK, Sharma V & van Kuppevelt TH 2017 'CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis' Kidney International 93, (3) 626-642 , DOI PEARL
Cunliffe M, Hollingsworth A, Bain C, Sharma V & Taylor JD 2017 'Algal polysaccharide utilisation by saprotrophic planktonic marine fungi' Fungal Ecology 30, 135-138 , DOI PEARL
Tremp AZ, Sharma V, Carter V, Lasonder E & Dessens JT 2017 'LCCL protein complex formation in Plasmodium is critically dependent on LAP1' Mol Biochem Parasitol Author Site , DOI PEARL
Bassiri K, Ferluga S, Sharma V, Syed N, Adams CL, Lasonder E & Hanemann CO 2017 'Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target' EBioMedicine , DOI PEARL
Sequiera Lester G, Sareen N, Sharma V, Choudhary R, Abu Al-Rub E, Moudgil M, Ravandi A & Dhingra S 2016 'Application of “Omics” to Assess the Inter Passage Variability in the Immunoprivilege of Mesenchymal Stem Cells' Circulation Research
Suárez-Cortes P, Sharma V, Bertuccini L, Costa G, Bannerman NL, Sannella AR, Williamson K, Klemba M, Levashina EA & Lasonder E 2016 'Comparative proteomics and functional analysis reveal a role of P. falciparum osmiophilic bodies in malaria parasite transmission' Molecular & cellular proteomics : MCP PEARL
Bouyer G, Reininger L, Ramdani G, D Phillips L, Sharma V, Egee S, Langsley G & Lasonder E 2016 'Plasmodium falciparum infection induces dynamic changes in the erythrocyte phospho-proteome' Blood cells, molecules & diseases 58, 35-44 PEARL
Zhou L, Lyons-Rimmer J, Ammoun S, Müller J, Lasonder E, Sharma V, Ercolano E, Hilton D, Taiwo I & Barczyk M 2015 'The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors' Oncogene 35, (26) 3443-3453 , DOI PEARL
Sharma V & Tikoo K 2014 'Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats' Mol Cell Biochem 388, (1-2) 95-111 Publisher Site
Costessi A, Mahrour N, Sharma V, Stunnenberg R, Stoel MA, Tijchon E, Conaway JW, Conaway RC & Stunnenberg HG 2012 'The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME' Plos One
Middeljans E, Wan X, Jansen PW, Sharma V, Stunnenberg HG & Logie C 2012 'SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes' Plos One
Shahhoseini M, Favaedi R, Baharvand H, Sharma V & Stunnenberg HG 2010 'Evidence for a dynamic role of the linker histone variant H1x during retinoic acid-induced differentiation of NT2 cells' FEBS Letters 4661-4664
Tikoo K, Singh K, Kabra D, Sharma V & Gaikwad AB 2008 'Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy' Free Radical Research 397-404
Tikoo K, Bhatt DK, Gaikwad AB, Sharma V & Kabra DG 2007 'Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats' FEBS Letters 2027-2035
Tikoo K, Tripathi DN, Kabra DG, Sharma V & Gaikwad AB 2007 'Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53' FEBS Letters 1071-1078
Conference Papers
Sharma V, de Lera A & Stunnenberg HG 2013 'Quantitative mass spectrometric analysis reveals the target acetylome of epigenetic inhibitor UVI5008' British Society for Proteome Research 03/12/2013 04/12/2013
Sharma V, de Lera A & Stunnenberg HG 2013 'Quantitative mass spectrometric analysis reveals the target acetylome of epigenetic inhibitor UVI5008' British Society for Proteome Research 03/12/2013 04/12/2013
Posters
Sharma V & Tikoo K Sharma V & Tikoo K 0 'Proteomic Approach to Identify Stage Specific Biomarkers in Streptozotocin Induced Diabetic Nephropathy' 0 0

Other academic activities

Supervision of Undergraduate, Post Graduate and PhD students. I also offer summer placement, Masters and Undergraduate research projects.

Links

http://scholar.google.co.uk/citations?user=lfBPnqQAAAAJ&hl=en&oi=ao